| GO |
B_14_23 |
GO:0033081 |
regulation of T cell differentiation in thymus |
2/29 |
28/18986 |
0.00083081235027594 |
0.0331896309761647 |
0.023970214559673 |
IL2RG/RASGRP1 |
2 |
| GO |
B_14_23 |
GO:0045785 |
positive regulation of cell adhesion |
5/29 |
499/18986 |
0.00086608741376446 |
0.0331896309761647 |
0.023970214559673 |
IL2RG/PREX1/RASGRP1/SASH3/TGFB1 |
5 |
| GO |
B_14_23 |
GO:1903039 |
positive regulation of leukocyte cell-cell adhesion |
4/29 |
284/18986 |
0.00086692612780691 |
0.0331896309761647 |
0.023970214559673 |
IL2RG/RASGRP1/SASH3/TGFB1 |
4 |
| GO |
B_14_23 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway |
2/29 |
29/18986 |
0.00089150965784018 |
0.0331896309761647 |
0.023970214559673 |
CBL/TGFB1 |
2 |
| GO |
B_14_23 |
GO:0035710 |
CD4-positive, alpha-beta T cell activation |
3/29 |
129/18986 |
0.00098400344500021 |
0.0350102737399463 |
0.0252851191368195 |
CRACR2A/IL2RG/SASH3 |
3 |
| GO |
B_14_23 |
GO:1901186 |
positive regulation of ERBB signaling pathway |
2/29 |
31/18986 |
0.00101913289636212 |
0.0350102737399463 |
0.0252851191368195 |
CBL/TGFB1 |
2 |
| GO |
B_14_23 |
GO:0000077 |
DNA damage checkpoint signaling |
3/29 |
131/18986 |
0.00102874573503732 |
0.0350102737399463 |
0.0252851191368195 |
DGKZ/PPP2R5C/RFWD3 |
3 |
| GO |
B_14_23 |
GO:0046632 |
alpha-beta T cell differentiation |
3/29 |
133/18986 |
0.00107475897896996 |
0.0350102737399463 |
0.0252851191368195 |
CRACR2A/IL2RG/SASH3 |
3 |
| GO |
B_14_23 |
GO:0050864 |
regulation of B cell activation |
3/29 |
133/18986 |
0.00107475897896996 |
0.0350102737399463 |
0.0252851191368195 |
IL2RG/SASH3/TGFB1 |
3 |
| GO |
B_14_23 |
GO:0002708 |
positive regulation of lymphocyte mediated immunity |
3/29 |
136/18986 |
0.00114619253811237 |
0.0364265579795224 |
0.0263079879094341 |
RASGRP1/SASH3/TGFB1 |
3 |